Navigation Links
Golden Meditech Celebrates Grand Opening of Taiwan Representative Office
Date:9/6/2011

HONG KONG, Sept. 6, 2011 /PRNewswire-Asia/ -- Golden Meditech Holdings Limited ("Golden Meditech", together with its subsidiaries collectively as the "Group", - 801.HK; 910801.TW), which embodies a leading medical devices enterprise, a major brand name in haematology hospital and the largest stem cell cord blood banking operator in China, is pleased to announce the launch of its Taiwan representative office today.

With a track record in China for establishing the largest stem cell cord blood banking corporation, developing a premium hospital service business, and now, building a cross-straits healthcare enterprise, Mr. Kam Yuen, Chairman and CEO of Golden Meditech, in known as a pioneer in China's healthcare industry. With his remarkable insights and ability to stay ahead of industry trends while having the attention and tenacity as an entrepreneur, Mr. Kam has set his sight on the substantial opportunities in Taiwan's medical and bio-tech industries. The Group has already set foot in Taiwan via issuing Taiwan Depositary Receipts ("TDR") on the Taiwan Stock Exchange in January 2011. Mr. Kam is of the view that the launch of Economic Cooperation Framework Agreement ("ECFA") and the policy allowing for easier access between the straits will foster the development of premium healthcare service sector. Whereas Taiwan has readily accessible medical expertise and resources, with the launch of the new Taiwan representative office, the Group will be able to better leverage its operative advantage, expand its industry reach and create greater opportunities with its Taiwan counterpart for greater growth.  

Golden Meditech is the first and one the largest blood-related medical device manufacturers in China with its key product, the Autologous Blood Recovery System ("ABRS") accounting for 80% share of the top-tier hospital market. China's ongoing medical reform has created an excellent opportunity for the Group as a pioneer in the areas of hospital services and hospital management. The Group's hospital management business is the first wholly-owned foreign entity to provide nation-wide hospital management services in China while its specialist haematology hospitals, operated under the "Daopei Hospital" brand, is a name to be reckoned in its specialty. Just recently, the Group has acquired a reputable operation, the Shanghai East International Medical Centre in Shanghai, to further strengthen its strategic position as a premium medical service provider

The Group's healthcare service portfolio also includes the first dedicated medical insurance information process and claims settlement business process outsourcing (BPO) service provider, GM Medicare Company Limited, launched in April 2011, and a stake in China Cord Blood Corporation ("CCBC"; NYSE listed stock code CO:US), the largest cord blood banking operator in China and a major shareholder of CORDLIFE LTD, a leading pan-Asian cord blood bank operator.

China's medical reform will be a key focus in the Twelve National People's Congress's Five-Year-Plan. The Group's healthcare services business will be a key beneficiary of the reform and a key growth driver to its growing business operations. Mr. Kam believes the progressive nature of the new medical reform and the ECFA has orchestrated the perfect opportunity for healthcare enterprises across the straits to form strategic partnerships and create a platform to connect and leverage on each other's strengths and capabilities. Golden Meditech maintains a positive outlook on Taiwan's healthcare industry, as the Group anticipates new opportunities for growth and collaboration with its ample resources in experience and competitive advantages. As it expands it foothold in Taiwan, the Group is also looking forward to identify suitable management talents and medical professions with its Taiwanese partners for even greater achievements In the future.

About Golden Meditech Holdings LimitedGolden Meditech Holdings Limited is China's leading integrated-healthcare devices and service operator, and the first medical device enterprise that was publicly listed outside of the PRC on the Stock Exchange of Hong Kong Limited (HKEx) and the Taiwan Stock Exchange (TSE). Golden Meditech is a first-mover in China, having established dominant positions in medical devices and healthcare services markets over the years, thanks to its strengths in innovation and market expertise and the ability to capture emerging market opportunities. Going forward, the Group will continue to pursue a leading position in China's healthcare industry both through organic growth and strategic expansion.For more information, please contact:Investor Relations DepartmentGolden Meditech Holdings LimitedAddress: 48/F, Bank of China Tower, 1 Garden Road, Central, Hong KongTel:   +852-3605-8180Fax:   +852-3605-8181Email: ir@goldenmeditech.com
'/>"/>

SOURCE Golden Meditech Holdings Limited
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Golden Meditech FY2010-11 Annual Results
2. Golden Meditech Acquires Shanghai East International Medical Centre
3. Golden Meditech to Increase Stake in NYSE-listed Affiliate -- China Cord Blood Corporation to 39.5%
4. Golden Meditech Chairman Increases Stake in Company
5. Fenwal, Golden Meditech Complete Definitive Agreement to Form Joint Venture in China
6. Golden Meditech Acquires Remaining Stake in Chinese Herbal Medicine Business
7. Golden Meditech to Form Strategic Alliance with Long Bon International
8. Golden Meditech as First Chinese Healthcare Enterprise to Obtain Approval for Taiwan Depositary Receipts Offering
9. Golden Meditech Announces Plan to Issue Taiwan Depository Receipts
10. Golden Meditech Announces Annual Results for FY 2009/10
11. Roche Diabetes Care Celebrates Second Annual Infusion Site Awareness Week, Aug. 29-Sept. 4
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... The Academy of Managed Care Pharmacy (AMCP) ... would allow biopharmaceutical companies to more easily share health ... and coverage decisions, a move that addresses the growing ... The recommendations address restrictions in the sharing of ... label, a prohibition that hinders decision makers from accessing ...
Breaking Medicine Technology:
(Date:6/26/2016)... Battle Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... abuse, joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table ... held in honor of the city’s history as home to some of the world’s ...
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
Breaking Medicine News(10 mins):